Transcatheter Aortic Valve Implantation (TAVI) at the MUHC: a Health Technology Assessment
McGregor M, Esfandiari S
Record ID 32010000177
English
Authors' recommendations:
In spite of a high mortality risk, and uncertain long‐term prognosis, transcatheter aortic valve implantation is a feasible procedure that clearly gives survivors symptomatic relief and probably causes some overall extension of life . It can be carried out at the MUHC at a net cost of approximately $24,024 per patient. The budget impact of the anticipated 30 patients per year would be approximately $720,719
Details
Project Status:
Completed
URL for project:
http://www.mcgill.ca/files/tau/TAVI_REPORT.pdf
Year Published:
2009
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Aortic Valve Insufficiency
- Aortic Valve Stenosis
- Heart Valve Prosthesis
Contact
Organisation Name:
Technology Assessment Unit of the McGill University Health Centre (MUHC)
Contact Address:
Technology Assessment Unit of the MUHC, Centre for Outcomes Research and Evaluation (CORE), Research Institute of the McGill University Health Centre, 5252 boul. de Maisonneuve, Bureau 3F.50, Montreal, Quebec H4A 3S5
Contact Name:
nandini.dendukuri@mcgill.ca
Contact Email:
nandini.dendukuri@mcgill.ca
Copyright:
Technology Assessment Unit of the McGill University Health Centre (MUHC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.